Kendall Capital Management Collegium Pharmaceutical, Inc Transaction History
Kendall Capital Management
- $331 Million
- Q4 2024
A detailed history of Kendall Capital Management transactions in Collegium Pharmaceutical, Inc stock. As of the latest transaction made, Kendall Capital Management holds 17,760 shares of COLL stock, worth $511,843. This represents 0.15% of its overall portfolio holdings.
Number of Shares
17,760
Previous 13,500
31.56%
Holding current value
$511,843
Previous $521,000
2.5%
% of portfolio
0.15%
Previous 0.17%
Shares
2 transactions
Others Institutions Holding COLL
# of Institutions
246Shares Held
37.2MCall Options Held
59.3KPut Options Held
9.5K-
Black Rock Inc. New York, NY5.79MShares$167 Million0.0% of portfolio
-
Eventide Asset Management, LLC Boston, MA2.64MShares$76 Million1.45% of portfolio
-
Rubric Capital Management LP New York, NY2.35MShares$67.7 Million1.11% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.28MShares$65.8 Million0.0% of portfolio
-
Pacer Advisors, Inc. Malvern, PA2.14MShares$61.7 Million0.15% of portfolio
About COLLEGIUM PHARMACEUTICAL, INC
- Ticker COLL
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 34,126,200
- Market Cap $984M
- Description
- Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...